Evaluation of acinetobacter baumannii pneumonia among critically ill patients in a tertiary care hospital in Saudi Arabia
- PMID: 32462088
- PMCID: PMC7240323
- DOI: 10.1016/j.heliyon.2020.e03976
Evaluation of acinetobacter baumannii pneumonia among critically ill patients in a tertiary care hospital in Saudi Arabia
Abstract
Microbiology; Bacteria; Antimicrobial; Infectious disease; Medical microbiology; Pharmacology; Pneumonia; Acinetobacter baumannii; Colistin.
Keywords: Acinetobacter baumannii; Antimicrobial; Bacteria; Colistin; Infectious disease; Medical microbiology; Microbiology; Pharmacology; Pneumonia.
© 2020 The Authors.
Figures
References
-
- Kalil A.C., Metersky M.L., Klompas M., Muscedere J., Sweeney D.A., Palmer L.B. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin. Infect. Dis. 2016;63(5):e61–e111. - PMC - PubMed
-
- Özvatan T., Akalin H., Sinirtaş M., Ocakoglu G., Yilmaz E., Heper Nosocomial Acinetobacter pneumonia: treatment and prognostic factors in 356 cases. Respirology. 2016;21(2):363–369. - PubMed
-
- Kwa A.L.H., Low J.G.H., Lee E., Kurup A., Chee H.-L., Tam V.H. The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia. Diagn. Microbiol. Infect. Dis. 2007;58(1):99–104. - PubMed
-
- Gootz T.D., Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev. Anti Infect. Ther. 2008;6(3):309–325. - PubMed
LinkOut - more resources
Full Text Sources
